ASP.TO - Acerus Pharmaceuticals Corp | |||
---|---|---|---|
0 (0%) | |||
Open: | Prev Close: | ||
High: | Low: | ||
Volume: | Market Cap: | ||
Year High: | Year Low: |
Stock Technical Analysis | |
---|---|
Overall | |
Targets | Six months: 0.86 One year: 1.19 |
Supports | Support1: 0.28 Support2: 0.23 |
Resistances | Resistance1: 0.74 Resistance2: 1.02 |
Pivot Point | 0.36 |
Moving Averages | MA(5): 0.36 MA(20): 0.36 MA(100): 0.96 MA(250): 3.22 |
MACD | MACD(12,26): -0.03 Signal(12,26,9): -0.04 |
Stochastic Oscillator | %K(14,3): 0.36 %D(3): |
RSI | RSI(14): 25.79 |
52-Week | High: 10.00 Low: 0.28 Change(%): -96.4 |
Average Volume(K) | 3-Month: 132 10-Days: |
Moving Averages analysis |
---|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term. |
Bollinger Bands Analysis |
---|
ASP.TO has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to ASP.TO's normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend. |
Stock Technical Analysis Charts |
---|
Company news |
---|
Mon, 10 Jul 2023 Acerus Update - Yahoo Finance Thu, 25 May 2023 Acerus Update - Yahoo Finance Tue, 14 Mar 2023 Acerus Announces Commencement of Court-Approved Sale and Investment Solicitation Process - GlobeNewswire Thu, 10 Mar 2016 Ottawa Senators owner Eugene Melnyk files notice that he's suing Acerus Pharma - CBC.ca Tue, 08 Mar 2016 Eugene Melnyk suing Acerus for 'gross mismanagement' - The Globe and Mail Mon, 28 Feb 2022 Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva - GlobeNewswire |
Financials | |
---|---|
EPS | |
EPS Est. Current Year | |
EPS Est. Next Year | |
EPS Est. Next Quarter | |
Forward EPS | |
Shares Out. (M) | |
Shares Float (M) | |
Book Value (p.s.) | |
PEG Ratio | |
Profit Margin | |
Operating Margin | |
Return on Assets (ttm) | |
Return on Equity (ttm) | |
Qtrly Rev. Growth | |
Gross Profit (p.s.) | |
Sales Per Share | |
EBITDA (p.s.) | |
Qtrly Earnings Growth | |
Operating Cash Flow (M) | |
Levered Free Cash Flow (M) |
Valuation | |
---|---|
P/E | |
P/E Growth Ratio | |
P/BV | |
P/S | |
P/CF |